$Moderna, Inc.(MRNA)$ An activ

Like
Comment
Favorite

$Moderna, Inc.(MRNA)$ An activist investor has been talking about the competition for new drugs. Even with Keytruda, 44% of stage III patients see their cancer come back or die within five years. Three Phase 3 trials that added other immunotherapies to drugs like Keytruda all failed. Moderna is the only one that succeeded. Waiting for the standalone numbers to come out.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":622800113468136,"tweetId":"622800113468136","gmtCreate":1793073175000,"gmtModify":1793090482956,"author":{"id":10000000000011390,"idStr":"10000000000011390","authorId":10000000000011390,"authorIdStr":"10000000000011390","name":"Judith Rose","avatar":"https://static.tigerbbs.com/1f212ccc608ec16837ed048bdcd201cd","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":10,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://ttm.financial/S/MRNA\">$Moderna, Inc.(MRNA)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;An activist investor has been talking about the competition for new drugs. Even with Keytruda, 44% of stage III patients see their cancer come back or die within five years. Three Phase 3 trials that added other immunotherapies to drugs like Keytruda all failed. Moderna is the only one that succeeded. Waiting for the standalone numbers to come out.</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://ttm.financial/S/MRNA\">$Moderna, Inc.(MRNA)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;An activist investor has been talking about the competition for new drugs. Even with Keytruda, 44% of stage III patients see their cancer come back or die within five years. Three Phase 3 trials that added other immunotherapies to drugs like Keytruda all failed. Moderna is the only one that succeeded. Waiting for the standalone numbers to come out.</p></body></html>","text":"$Moderna, Inc.(MRNA)$ An activist investor has been talking about the competition for new drugs. Even with Keytruda, 44% of stage III patients see their cancer come back or die within five years. Three Phase 3 trials that added other immunotherapies to drugs like Keytruda all failed. Moderna is the only one that succeeded. Waiting for the standalone numbers to come out.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/622800113468136","repostId":0,"isVote":1,"tweetType":1,"viewCount":185,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["MRNA"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":312,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}